1,782.5
+2.27%
Close of 9 Nov 2026, in JPY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Olympus
Its shares trade on Tokyo Stock Exchange under the ticker 7733.T. It has been listed since 16 May 1949. In the fiscal year to 31 March 2026, it reported revenue of ¥1.01trn and net income of ¥68.17bn. At that date it held total assets of ¥1.54trn and shareholders' equity of ¥812.04bn.
Olympus Corp. engages in the manufacture and sale of precision machineries and instruments. The company is headquartered in Shinjuku, Tokyo-To. The firm operates in five business segments. The Endoscopy segment provides gastrointestinal endoscopy, surgical endoscopy, endoscopy systems and repair services. The Therapeutic Equipment segment provides endoscopic treatment tools, energy devices, urology, gynecology and otolaryngology products. The Scientific segment provides biological microscope, industrial microscope, industrial endoscope and non-destructive inspection equipment. The Imaging segment provides digital cameras and recording machines. The Others segment is engaged in the manufacture and sale of biomaterials. The firm is also engaged in the financial investment business.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 16 May 1949
- Employees
- 35,124
- Website
- olympus.co.jp ↗
Leadership
Pay as last reported
- Mr. Yasuo TakeuchiChairman of the Executive Board, Representative Executive Officer, ESG Officer, Director, since 2009¥497.0m
- Mr. Sumitaka FujitaChairman of the Board of Directors, Independent Director
- Mr. Tatsuya IzumiExecutive Officer, Chief Financial Officer
- Mr. Shigeto OhtsukiExecutive Officer, Chief Human Resource Officer
- Mr. Andre RogganExecutive Officer, Chief Technology Officer¥462.0m
- Mr. John ChepelExecutive Officer, Chief Medical Officer
- Mr. Frank DrewalowskiExecutive Officer, Chairman of Subsidiary¥459.0m
- Mr. Masahito GotoExecutive Officer
- Mr. Hironobu KawanoExecutive Officer
- Ms. Gabriela KaynorExecutive Officer, Chief Strategy Officer¥218.0m
- Mr. Stephen KneeboneExecutive Officer
- Mr. Tetsuo KobayashiExecutive Officer, Chief Manufacturing and Supply Officer¥119.0m
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 91
- Environment
- 99
- Social
- 99
- Governance
- 74
- Direct emissions (scope 1)
- 27,255 t
- Energy emissions (scope 2)
- 55,175 t
- Value chain emissions (scope 3)
- 787,822 t
- Women in the workforce
- 38.4%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Olympus Corp possesses several key strengths that contribute to its success in the market. Firstly, the company has a strong brand reputation and recognition globally, built over many years of delivering high-quality products. This enables Olympus Corp to attract a loyal customer base and maintain market share. Additionally, the company has a diverse product portfolio that includes cameras, medical imaging systems, and scientific equipment, which allows it to cater to various industries and customer segments. Moreover, Olympus Corp has a strong commitment to innovation, constantly introducing new and advanced technologies in their products, which keeps them competitive in the market.
Weaknesses
- While Olympus Corp has many strengths, it is not without weaknesses. One weakness is its heavy reliance on the Asian market, particularly in Japan, as its primary source of revenue. This makes the company vulnerable to economic fluctuations and market conditions specific to that region. In addition, the company has faced significant financial challenges in the past due to accounting scandals, which damaged its reputation and eroded investor confidence. Olympus Corp must address these weaknesses and diversify its revenue sources to mitigate potential risks.
Opportunities
- Olympus Corp has several opportunities to capitalize on in the market. Firstly, there is a growing demand for medical imaging and healthcare equipment globally, driven by an aging population and advancements in medical technology. As a leading provider of medical imaging systems, Olympus Corp is well-positioned to tap into this market and expand its customer base. Additionally, the increasing adoption of digital cameras and advancements in photography present opportunities for the company to introduce innovative camera products that cater to evolving customer needs. Furthermore, expanding into emerging markets, such as China and India, provides Olympus Corp with a chance to reach new customers and drive revenue growth.
Threats
- Despite its strengths and opportunities, Olympus Corp faces several threats in the market. One major threat is intense competition from other well-established players in the industry, both domestically and internationally. This can result in price wars and reduced market share if Olympus Corp fails to differentiate itself effectively. Additionally, rapid technological advancements and changing consumer preferences pose a threat to the company's products, requiring continuous investment in research and development to stay ahead. Moreover, geopolitical and economic uncertainties, such as trade disputes and currency fluctuations, can impact the company's operations and sales, particularly in international markets.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.